ENCOURAGE: Evaluating Community Peer Advisors and Diabetes Outcomes in Rural Alabama (ENCOURAGE)

March 9, 2016 updated by: Monika M. Safford, Weill Medical College of Cornell University
It is unclear whether peer coaching is effective in minority populations living with diabetes in hard-to-reach, under resourced areas such as the rural South. We examined the effect of an innovative peer coaching intervention plus brief education vs. brief education alone on diabetes outcomes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The purpose of this project was to provide robust evidence on the effectiveness of a peer support intervention in improving diabetes outcomes by conducting a group-randomized, controlled implementation trial of a volunteer peer support intervention.

The study had three specific aims:

Aim 1. In Phase I (months 0-8), to perform a qualitative needs assessment with peer advisors and health care providers to inform peer advisor roles and responsibilities (i.e., the intervention) and peer advisor recruitment strategies, curriculum and training; and patient recruitment plans.

Aim 2. Also in Phase I, to pilot our collaboratively developed intervention and, based on pilot test results, to recruit and train peer advisors for the intervention, and begin patient recruitment.

Aim 3. In Phase II (months 9-32), conduct the group randomized implementation trial and evaluate it using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework.

Study Type

Interventional

Enrollment (Actual)

424

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 19 or older in age, diagnosed with diabetes, under the care of a doctor

Exclusion Criteria:

  • not community dwelling, less than 19 years old, pregnant, end-stage medical conditions with limited life expectancy, no access to telephone, does not speak english

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group
Participants received 1-hour group diabetes education class covering diabetes basics, healthy eating, stress reduction, physical activity, social support, and how to get the most out of their doctors visit. Participants also received a diabetes report card showing their Hba1c, blood pressure, ldl cholesterol, and body weight.
Experimental: Encourage study

Participants in the intervention arm were paired with a peer coach, interacting by telephone weekly for the first 8 weeks and then monthly for a total of 10 months.

Participants also received 1-hour group diabetes education class covering diabetes basics, healthy eating, stress reduction, physical activity, social support, and how to get the most out of their doctors visit. Participants also received a diabetes report card showing their Hba1c, blood pressure, ldl cholesterol, and body weight.

This intervention tested the effects of a peer coaching program plus brief diabetes education versus brief diabetes education alone on diabetes outcomes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycated hemoglobin (A1c)
Time Frame: Change in A1c in 12 months
fingerstick, point-of-care a1c test
Change in A1c in 12 months
Blood pressure
Time Frame: Change in blood pressure measure in 12 months
Measured using digital automated blood pressure monitor
Change in blood pressure measure in 12 months
LDL cholesterol
Time Frame: Change in LDL cholesterol in 12 month
measured using finger stick, spectrophotometer to measure LDL cholesterol
Change in LDL cholesterol in 12 month
diabetes self-care behaviors questionnaire
Time Frame: Change in diabetes self-care behaviors at 12 months
aspects of diabetes self-management such as taking medications as directed, self-report of exercise, and eating behaviors
Change in diabetes self-care behaviors at 12 months
depressive symptoms
Time Frame: change in depressive symptoms at 12 months
self-report using Patient Health Questionnaire 8 (PHQ8)
change in depressive symptoms at 12 months
quality of life
Time Frame: Change in quality of life measures at 12 months
self-report using Short form-1 (SF1), and Euroquol (EQ-5D)
Change in quality of life measures at 12 months
patient activation
Time Frame: change in patient activation in 12 months
self-report using the 13 item Patient Activation Measure (PAM13)
change in patient activation in 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
body mass index
Time Frame: change in BMI in 12 months
weight measured using digital scale, height measured using stadiometer
change in BMI in 12 months
diabetes knowledge
Time Frame: change in diabetes knowledge in 12 months
assessed using the Spoken Knowledge in Low Literacy in Diabetes Scale
change in diabetes knowledge in 12 months
trust in physicians
Time Frame: change in trust in physicians in 12 months
assessed using the Trust in Physicians Scale
change in trust in physicians in 12 months
composite measure of healthcare utilization
Time Frame: Change in health care utilization in 12 months
self-report by participant, number of times utilized healthcare services
Change in health care utilization in 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2009

Primary Completion (Actual)

February 1, 2012

Study Completion (Actual)

February 1, 2012

Study Registration Dates

First Submitted

May 29, 2015

First Submitted That Met QC Criteria

June 1, 2015

First Posted (Estimate)

June 2, 2015

Study Record Updates

Last Update Posted (Estimate)

March 10, 2016

Last Update Submitted That Met QC Criteria

March 9, 2016

Last Verified

March 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data will stay at UAB

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus

Clinical Trials on ENCOURAGE Study

Subscribe